India Mammography Market Assessment, By Product [Digital Systems, 3D Systems, Analog Systems, Others], By Technology [2D Mammography, Breast Tomosynthesis/3D Mammography, CAD Mammography], By Type [Screening Mammography, Diagnostic Mammography], By End-us

India Mammography Market Assessment, By Product [Digital Systems, 3D Systems, Analog Systems, Others], By Technology [2D Mammography, Breast Tomosynthesis/3D Mammography, CAD Mammography], By Type [Screening Mammography, Diagnostic Mammography], By End-user [Hospitals, Diagnosis Centers, Specialty Clinics, Others], By Region, Opportunities and Forecast, FY2018-FY2032F

Egypt mammography market is projected to witness a CAGR of 7.20% during the forecast period 2024-2031, growing from USD 5.12 million in 2023 to USD 8.93 million in 2031. Egypt mammography market is driven by several factors which include increasing awareness of breast cancer screening, government initiatives and screening programs, enhanced public health campaigns, expanding healthcare infrastructure, coupled with integration of AI and machine learning. These factors collectively boost the demand for advanced imaging technologies and enhance accessibility, fueling the dynamic growth and evolution of the Egypt mammography market.

Mammography is a vital diagnostic tool used in the early detection of breast cancer, employing low-dose X-rays to create detailed images of breast tissue. This procedure is crucial for identifying abnormalities before symptoms arise, significantly improving treatment outcomes. There are two main types of mammograms: screening and diagnostic. Screening mammograms are performed on asymptomatic women to detect potential issues early, while diagnostic mammograms are used when symptoms are present, such as lumps or unusual pain. The process involves compressing the breast between two plates to obtain clear images, which may cause some discomfort but is essential for accurate results. Despite its effectiveness, mammography is not foolproof; it can yield false positives and negatives, necessitating further testing in some cases. Current guidelines recommend regular screenings starting at age 40, though individual risk factors should guide the frequency and timing of these exams. Overall, mammography remains a cornerstone in breast health, empowering women with the knowledge and tools to combat breast cancer effectively. As technology advances, so will techniques for finding cancer, and the evolution of mammography will continue to play a critical role in research and patient care.

Government Initiatives and Healthcare Investments

The Egyptian government has played a crucial role in boosting the market for mammography due to various strategic initiatives that they have been taking related to awareness programs and investments made for healthcare. To standardize existing and new healthcare facilities with an emphasis on rural areas, the government is working towards updating healthcare infrastructure to provide people with equitable access to essential diagnostic services. Regulatory reforms that have simplified the approval procedure for mammography equipment have convinced both domestic and international manufacturers to enter this market Public-private partnerships (PPPs) have further enhanced healthcare infrastructure, allowing for the sharing of resources and expertise. Moreover, integrating AI and machine learning into imaging technologies is set to revolutionize diagnostics in Egypt. These concerted efforts reflect the government's commitment to prioritizing healthcare development, ultimately leading to better outcomes for women and enhanced access to lifesaving mammography services.

For instance, in July 2024, the Central Bank of Egypt (CBE) launched the ""Your Health is a Commitment"" (Sehetak Amana) initiative, in partnership with the Baheya Foundation, as part of the National Strategy for the Empowerment of Egyptian Women. The program offers early breast cancer detection, free treatment services, and awareness seminars for women in the banking sector.

Increasing Incidence of Breast Cancer

The growing incidence of breast cancer in Egypt is significantly boosting the growth of the mammography market. With such rising new cases, increased improvements are needed for screening tools to diagnose such tumors at an early stage. Effective screening of breast cancer is important in detecting asymptomatic cases as it leads to less invasive treatments and better patient outcomes since tumors are diagnosed earlier before they progress. In Egypt, Mammography is still the recommended imaging technique for breast cancer screening. To improve breast cancer screening, treatment, and education, the Egyptian Ministry of Health has launched various initiatives, such as a patient support program with access to free medications, diagnostic tests, and emotional support for women diagnosed with breast cancer, which would help these women regularly go for a checkup. As more women become aware of the importance of early detection, they opt for mammograms, expanding services into underprivileged areas and creating more demand.

For instance, a comprehensive systematic review and meta-analysis from Egypt found that breast cancer was the most prevalent cancer among Egyptian females, constituting 42% of all cancer cases, with most cases being diagnosed at advanced stages.

Breast Tomosynthesis Segment Leads Market Share

The Egypt mammography market is being propelled by the breast tomosynthesis segment which has powerful imaging tools. As Egypt's healthcare facilities make significant investments in leading technologies, the adoption of breast tomosynthesis has been increasing at high speed. Growing radiologist awareness regarding its advanced diagnostic advantages aids in further solidifying the dominance of this segment. Its superior image resolution coupled with decreased diagnostic errors has made it the right choice for numerous institutions. Over time, further improvements as well as decreasing costs are helping to make breast tomosynthesis more practical across a range of care delivery contexts. For instance, the Diagnostic Radiology Department at Baheya Foundation boasts state-of-the-art mammogram devices and advanced screening techniques, including 3D mammography, Contrast-Enhanced Digital Mammography (CEDM), and stereotactic biopsy. This cutting-edge technology enhances the accuracy of breast cancer detection and diagnosis, enabling earlier and more precise identification of potential issues.

Lower Egypt Dominates the Mammography Market

North Egypt has become a favorable growth-boosting region due to numerous factors contributing positively to the mammography market. The region has a dense population and increased healthcare infrastructure investments, leading to the high accessibility of diagnostic services. Intensive medical technology in Lower Egypt and increased female-oriented health interventions led to greater mammography uptake, encouraging women/families to attend screenings that are conducted according to local customs. This is further driven by public health campaigns and government programs for early breast cancer detection, resulting in increasing penetration of the diagnostic devices segment. Additionally, partnerships between healthcare providers and non-governmental organizations have also strengthened screening programs as well as outreach activities. The presence of purely medical centers and facilities in Lower Egypt also contributes directly to its position being at the forefront on this market.

For instance, the Egyptian American Enterprise Fund (EAEF) is co-investing with Ezdehar Management, a leading Egypt-based private equity firm, to enhance healthcare infrastructure. The United States Agency for International Development (USAID), EAEF is a U.S. Government-seeded investment fund aimed at strengthening Egypt’s private sector. This partnership involves a minority stake co-investment to support THG in increasing bed capacity at its Zagazig hospital, renovating and expanding its hospital in Mansoura, and establishing a new facility in Mit Ghamr. Strengthening access to quality, affordable healthcare is a key development priority for EAEF, and this initiative highlights THG’s critical role in providing essential healthcare services in the Lowe Egypt region.

Future Market Scenario (2024 – 2031F)

The adoption of advanced imaging techniques such as AI and 3D mammography is likely to play an important role in the Egyptian mammography market. Artificial intelligence improves diagnostic accuracy by a more detailed examination of mammography images and the ability to identify slight anomalies that might otherwise be overlooked. It ensures earlier and more accurate detection of breast cancer while offering superior patient outcomes with fewer unnecessary repeat procedures. 3D mammography offers a more detailed three-dimensional view of breast tissue, which eliminates tissue overlap and enhances image clarity. This new capability can aid in the earlier detection of tumors, decreasing the rates of false positives and negatives. The greater availability of the infrastructure and lower cost will bring modern screenings within easy reach for more providers across Egypt. Apart from increasing the screening rate, better diagnostic capabilities are also expected to attract more public and private investment.

For instance, in October 2022, South Korean AI startup Lunit Inc. signed a reference site agreement with the Baheya Foundation for Detection & Treatment of Breast Cancer to implement its advanced mammography AI. This tool, trained on over 240,000 mammography images including approximately 50,000 cases of breast cancer, has received clearance in the United States and Europe and is approved for sale in over 35 countries worldwide.

Key Players Landscape and Outlook

The Egypt mammography market is consolidated with key players holding major shares of the market. Companies frequently pursue regulatory approvals to ensure their products meet stringent standards, which helps build credibility and trust. Additionally, mergers and acquisitions are common as firms seek to expand their market reach and capabilities. Collaborations between companies and healthcare institutions are also prevalent, facilitating the development of innovative solutions and enhancing access to advanced diagnostic technologies.

In June 2024, Siemens Healthineers AG (Siemens Healthineers) has recently unveiled a series of strategic initiatives and partnerships with the Unified Procurement Authority and the Ministry of Health, aimed at advancing healthcare infrastructure and services. To further support these initiatives, Siemens Healthineers Egypt is deploying eight mobile units equipped with the latest mammography systems. This addition underscores Siemens Healthineers' commitment to enhancing health outcomes through technological innovation and widespread service delivery.

In September 2021, GE HealthCare Technologies, Inc., Gustave Roussy Institute of Oncology, and the Egypt Ministry of Health partnered to establish Rapid Breast Cancer Diagnosis Clinics in Egypt. This collaboration aims to enhance the speed and quality of breast cancer diagnosis, while also reducing the overall costs of care—from initial consultation and diagnosis to subsequent treatment. By leveraging advanced technologies and expertise, the initiative seeks to improve patient outcomes and streamline the diagnostic process, making high-quality care more accessible and efficient.